avapro and endothelin-1
avapro has been researched along with endothelin-1 in 12 studies
Research
Studies (12)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Cattaruzza, M; Hecker, M; Lauth, M | 1 |
| Belloni, AS; Cavallin, M; Mazzocchi, G; Nussdorfer, GG; Pessina, AC; Rossi, GP; Sartore, S | 1 |
| Belloni, AS; Kreutz, R; Nussdorfer, GG; Paul, M; Pessina, AC; Rossi, GP; Seccia, TM | 1 |
| Hallberg, P; Kahan, T; Karlsson, J; Kurland, L; Liljedahl, U; Lind, L; Malmqvist, K; Melhus, H; Michaëlsson, K; Nyström, F; Ohman, KP; Syvänen, AC | 1 |
| Cachofeiro, V; Cediel, E; de Las Heras, N; Lahera, V; Sanz-Rosa, D; Velasco, O | 1 |
| Ferrannini, E; Santini, E; Solini, A | 1 |
| Barden, A; Beilin, LJ; Croft, KD; Puddey, IB; Tsai, IJ | 1 |
| Batenburg, WW; Bhaggoe, UM; Clahsen-van Groningen, MC; de Vries, R; Domenig, O; Friesema, EC; Garrelds, IM; Hoorn, EJ; Jan Danser, AH; Leijten, FP; Poglitsch, M; Roksnoer, LC; van Veghel, R | 1 |
| Chang, BC; Chen, WD; Liu, L; Yang, P; Zhang, Y | 1 |
| Belloni, AS; Buccella, V; Calò, LA; Caroccia, B; Gioco, F; Guerzoni, E; Guidolin, D; Montini, B; Pagnin, E; Petrelli, L; Piazza, M; Ravarotto, V; Rossi, GP; Seccia, TM | 1 |
| Chen, JW; Dai, B; Han, MX; Wang, ZZ; Zhang, GX; Zhang, H | 1 |
| Badawy, AES; Habib, E; Hasanin, AH; Hussein Mohamed, R; Khairy, E; Mahmoud, D; Mohammed Abdulsalam, T | 1 |
Trials
1 trial(s) available for avapro and endothelin-1
| Article | Year |
|---|---|
Gender-specific association between preproendothelin-1 genotype and reduction of systolic blood pressure during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).
Topics: Antihypertensive Agents; Atenolol; Biphenyl Compounds; Blood Pressure; Endothelin-1; Female; Genotype; Humans; Hypertension; Hypertrophy, Left Ventricular; Irbesartan; Male; Middle Aged; Polymorphism, Genetic; Sex Factors; Tetrazoles; Treatment Outcome | 2004 |
Other Studies
11 other study(ies) available for avapro and endothelin-1
| Article | Year |
|---|---|
ACE inhibitor and AT1 antagonist blockade of deformation-induced gene expression in the rabbit jugular vein through B2 receptor activation.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Cells, Cultured; Endothelin-1; Gene Expression Regulation; Glyceraldehyde-3-Phosphate Dehydrogenases; In Vitro Techniques; Irbesartan; Male; Peptide Fragments; Perfusion; Pressure; Rabbits; Ramipril; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B2; Receptor, Endothelin B; Receptors, Angiotensin; Receptors, Bradykinin; Receptors, Endothelin; RNA, Messenger; Swine; Tetrazoles; Transfection; Vasoconstriction | 2001 |
Aortic smooth muscle cell phenotypic modulation and fibrillar collagen deposition in angiotensin II-dependent hypertension.
Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Genetically Modified; Antihypertensive Agents; Aorta; Biphenyl Compounds; Bosentan; Calcium Channel Blockers; Collagen; Dansyl Compounds; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelin-1; Hypertension; Immunohistochemistry; Irbesartan; Male; Muscle, Smooth, Vascular; Nifedipine; Rats; Rats, Sprague-Dawley; Sulfonamides; Tetrazoles | 2002 |
Cardiac fibrosis occurs early and involves endothelin and AT-1 receptors in hypertension due to endogenous angiotensin II.
Topics: Angiotensin II; Animals; Animals, Genetically Modified; Antihypertensive Agents; Biphenyl Compounds; Bosentan; Cardiomyopathies; Dansyl Compounds; Disease Models, Animal; Endothelin-1; Fibrosis; Hypertension; Irbesartan; Male; Rats; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Receptors, Cell Surface; Sulfonamides; Tetrazoles; Time Factors; Vasoconstrictor Agents | 2003 |
AT-1 receptor antagonism modifies the mediation of endothelin-1, thromboxane A2, and catecholamines in the renal constrictor response to angiotensin II.
Topics: Adrenergic alpha-Antagonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Biphenyl Compounds; Catecholamines; Dose-Response Relationship, Drug; Endothelin-1; Irbesartan; Male; Potassium Chloride; Prazosin; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Renal Circulation; Tetrazoles; Thromboxane A2; Vasoconstrictor Agents | 2005 |
Enhanced angiotensin II-mediated effects in fibroblasts of patients with familial hypercholesterolemia.
Topics: Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Arteriosclerosis; Biphenyl Compounds; Calcium; Case-Control Studies; Cell Proliferation; Cells, Cultured; Cholesterol, LDL; Dose-Response Relationship, Drug; Endothelin-1; Female; Fibroblasts; Heterozygote; Humans; Hyperlipoproteinemia Type II; Irbesartan; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase 2; Middle Aged; Receptor, Angiotensin, Type 1; Tetrazoles; Transforming Growth Factor beta | 2005 |
20-Hydroxyeicosatetraenoic acid synthesis is increased in human neutrophils and platelets by angiotensin II and endothelin-1.
Topics: Adult; Aged; Amidines; Angiotensin II; Angiotensin Receptor Antagonists; Biphenyl Compounds; Blood Platelets; Calcium Channels; Cells, Cultured; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Endothelin-1; Humans; Hydroxyeicosatetraenoic Acids; Imidazoles; Ionophores; Irbesartan; Male; Middle Aged; Neutrophils; Oligopeptides; Peptides, Cyclic; Piperidines; Pyridines; Tetrazoles; Young Adult | 2011 |
Optimum AT1 receptor-neprilysin inhibition has superior cardioprotective effects compared with AT1 receptor blockade alone in hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Arterial Pressure; Atrial Natriuretic Factor; Biphenyl Compounds; Body Weight; Endothelin B Receptor Antagonists; Endothelin-1; Irbesartan; Kidney; Myocardium; Myocytes, Cardiac; Neprilysin; Oligopeptides; Organ Size; Piperidines; Protease Inhibitors; Rats; Receptor, Angiotensin, Type 1; Receptor, Endothelin B; Renin-Angiotensin System; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Tetrazoles; Thiorphan; Up-Regulation; Vasoconstriction; Vasodilation | 2015 |
[Effect of Tripterygium glycosides on expression of hypoxia inducible factor-1α and endothelin-1 in kidney of diabetic rats].
Topics: Animals; Biphenyl Compounds; Blood Glucose; Blood Urea Nitrogen; Creatinine; Diabetes Mellitus, Experimental; Endothelin-1; Glycosides; Hypoxia-Inducible Factor 1, alpha Subunit; Irbesartan; Kidney; Male; Rats; Rats, Sprague-Dawley; Tetrazoles; Tripterygium | 2015 |
Endothelin-1 Drives Epithelial-Mesenchymal Transition in Hypertensive Nephroangiosclerosis.
Topics: Actins; Angiotensin Receptor Antagonists; Animals; Animals, Genetically Modified; Biphenyl Compounds; Bosentan; Cadherins; Endothelin B Receptor Antagonists; Endothelin-1; Epithelial-Mesenchymal Transition; Fibrosis; Humans; Hypertension; Irbesartan; Kidney; Kidney Diseases; Kidney Tubules, Proximal; Oligopeptides; Piperidines; Rats; Receptor, Endothelin B; rho-Associated Kinases; Signal Transduction; Sulfonamides; Tetrazoles | 2016 |
Antihypertensive properties of a traditional Chinese medicine GAO-ZI-YAO in elderly spontaneous hypertensive rats.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Blood Pressure; Cytokines; Drugs, Chinese Herbal; Endothelin-1; Hypertension; Irbesartan; Male; Medicine, Chinese Traditional; Nitric Oxide; Rats; Rats, Inbred SHR; Vascular Endothelial Growth Factor A | 2020 |
Angiotensin receptor-neprilysin inhibitor (thiorphan/irbesartan) improved cardiac function in a rat model of myocardial ischemic reperfusion injury.
Topics: Animals; Cardiotonic Agents; Endothelin-1; Irbesartan; Male; Myocardial Reperfusion Injury; Myocardium; Neprilysin; Rats; Rats, Wistar; Receptors, Angiotensin; Thiorphan | 2023 |